hydrogen and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

hydrogen has been researched along with (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arola, S; Hirvonen, J; Kuga, S; Laaksonen, P; Laaksonen, T; Linder, MB; Peltonen, L; Serimaa, R; Torkkeli, M; Valo, H1

Other Studies

1 other study(ies) available for hydrogen and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

ArticleYear
Drug release from nanoparticles embedded in four different nanofibrillar cellulose aerogels.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2013, Sep-27, Volume: 50, Issue:1

    Topics: Beclomethasone; Calorimetry, Differential Scanning; Cellulose; Drug Carriers; Drug Compounding; Freeze Drying; Hydrogels; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Nanofibers; Nanoparticles; Particle Size; Powder Diffraction; Solubility; Spectroscopy, Fourier Transform Infrared; Surface Properties

2013